Copper Intrauterine Device

Introduction Overview

Generic Name

Copper intrauterine device

Brand Name

Paragard

Dosage Form

Intrauterine device (IUD)

Drug Class

Miscellaneous vaginal agents

Pharmacokinetics

Absorption:
The active component of Paragard is copper, which is locally released inside the uterine cavity. Unlike systemic hormonal contraceptives, Paragard does not involve absorption of active ingredients into systemic circulation for contraceptive effect. Instead, copper ions are continuously released from the copper wire wrapped around the T-shaped plastic frame inside the uterine cavity, exerting local effects in the endometrium and on sperm function. There is minimal systemic absorption of copper, reducing the likelihood of systemic side effects related to copper exposure.

Distribution:
Once released, copper ions act locally within the uterine environment. Copper acts primarily at the level of the endometrium and the uterine lumen, interfering directly with sperm motility and viability. Systemic distribution of copper is limited, as the primary site of action is intrauterine. The copper IUD does not enter systemic circulation in measurable amounts, and copper levels in blood typically do not increase beyond normal physiologic limits.

Metabolism:
As an elemental metal, copper is not metabolized in the traditional sense by hepatic enzymes but rather is handled by the body's natural copper homeostasis pathways. The copper released from the IUD is eventually bound by local proteins or taken up by endometrial cells, and any excess copper entering systemic circulation is processed by normal physiological pathways involving binding to ceruloplasmin and hepatic excretion into bile.

Elimination:
Copper ions released into the uterine cavity are either sequestered locally or absorbed in small amounts systemically and excreted primarily via the hepatobiliary system into feces. The elimination of copper from the body follows normal copper homeostasis mechanisms. The Paragard IUD itself is physically removed by a healthcare provider as needed, with no pharmacological elimination required.

Dosage Forms

Available Dosage Forms:
- Paragard is available exclusively as a single dosage form: a small, flexible, T-shaped intrauterine device composed of a polyethylene frame with barium sulfate for radiopacity. The device is wrapped with a fine copper wire around the vertical stem and copper sleeves on the horizontal arms.
- The device has two flexible white threads attached to the lower stem to enable checking placement and facilitates removal.

Dosages for Adults and Adolescents:
- Paragard is a single-use device intended for placement inside the uterus.
- It provides continuous contraception for up to 10 years after insertion.
- There are no variable dosage strengths; the contraceptive efficacy depends on device presence and copper ion release, not on numeric dosing.

Specific Patient Populations:
- Paragard is designed for use in women seeking long-term, hormone-free contraception.
- It can be safely used by breastfeeding women though risks of uterine perforation may be increased if inserted during lactation.
- It is not appropriate for women with uterine anomalies, current pelvic infections, copper allergy, or Wilson's disease.
- Use in adolescents is acceptable following clinician evaluation.
- For removal or replacement, healthcare providers follow established clinical protocols.

Note: The Paragard IUD is a medical device rather than a pharmaceutical preparation with multiple dosage strengths or routes.

Mechanism Of Action

Paragard's primary mechanism of contraception is the continuous local release of copper ions within the uterine cavity. Copper is spermicidal; it impairs sperm motility and viability by creating a hostile intrauterine environment that inhibits sperm from fertilizing an ovum. The copper ions increase the concentration of copper ions and enhance leukocyte infiltration in the uterine and tubal fluids, causing local inflammatory reactions that are toxic to sperm and prevent fertilization.

At the cellular level, copper induces degradation of sperm cell membranes, impairs acrosomal reaction, and inhibits enzymes essential for sperm motility. Additionally, the device causes a low-grade aseptic inflammatory response in the endometrium, which alters the uterine lining and tubal fluid, further disrupting sperm function and possibly implantation.

The T-shaped plastic frame also physically occupies space within the uterus, which may contribute mechanically to the contraceptive effect by impeding implantation. Clinical studies suggest that while fertilization may occasionally occur, the predominant mode of contraceptive effect is the inhibition of sperm migration and fertilization.

Compared to hormonal IUDs or systemic contraceptives, Paragard offers a non-hormonal option that avoids systemic hormonal exposure and associated side effects. Research shows Paragard's efficacy to be approximately 99% over 10 years. Its mechanism remains effective through all menstrual cycles, making it ideal for women seeking long-term, reversible, hormone-free contraception.

Pharmacological Actions

Spermicidal action through continuous copper ion release
Induction of local uterine inflammatory response hostile to sperm
Inhibition of sperm motility and viability within the uterine cavity
Interference with fertilization processes at the level of fallopian tubes
Physical presence in the uterus mechanically preventing implantation
Production of altered uterine environment impairing sperm transport
Non-hormonal contraceptive effect avoiding systemic endocrine changes
Long-term reversible contraception lasting up to 10 years
Local copper ion toxicity to sperm without significant systemic absorption
Minimal systemic pharmacological actions due to local intrauterine activity

Therapeutic Or Clinical Uses

Long-term reversible contraception for women desiring hormone-free birth control
Prevention of pregnancy for up to 10 years after insertion
Suitable for women seeking non-hormonal contraceptive methods
Contraception option during breastfeeding with caution
Birth control for women unable or unwilling to use hormonal methods
Emergency contraception off-label use in some settings (review needed)
Contraception without systemic hormonal side effects
Ideal for women requiring long-term, low maintenance contraception
Alternative contraception for women with contraindications to hormonal therapies
Contraceptive choice for women with contraindications to estrogen-based methods

Side Or Adverse Effects

Menstrual changes including heavier and longer periods with spotting
Painful menstrual cramps (dysmenorrhea) and pelvic pain
Backache and lower abdominal discomfort especially after insertion
Anemia secondary to increased menstrual bleeding
Pain during sexual intercourse (dyspareunia)
Vaginal irritation and abnormal discharge
Partial or complete expulsion of the device occurring in approximately 2% of users
Embedment of device into the uterine wall complicating removal
Uterine perforation during insertion, potentially causing internal injury
Risk of pelvic inflammatory disease (PID) especially within first 20 days post insertion
Ectopic pregnancy if conception occurs with device in place
Rare systemic allergic reactions to copper or device materials
Dizziness, syncope, bradycardia, or seizures immediately post-insertion/removal in susceptible individuals
Spotting or breakthrough bleeding between periods
Serious infections including endometritis with potential fertility impact

Precautions

Do not insert if pregnancy is suspected or confirmed
Avoid in women with abnormal uterine anatomy or large fibroids distorting uterine cavity
Screen and treat active pelvic infections or cervicitis prior to insertion
Use cautiously in women prone to pelvic inflammatory disease or with multiple sexual partners
Monitor closely if inserted during postpartum or breastfeeding due to increased perforation risk
Assess for Wilson’s disease or copper allergy before use
Regular self-check of IUD threads recommended to ensure correct positioning
Advise patients to report unusual pain, bleeding, or signs of infection immediately
Use backup contraception if device displacement or expulsion is suspected
Remove device promptly if upper genital infections or endometritis occurs
Advise regarding increased menstrual bleeding and possible anemia risk
Not indicated for treatment of sexually transmitted infections; counsel accordingly
MRI scans may require caution; inform radiologist of IUD presence
Insertion should be performed by trained healthcare providers under aseptic conditions
Educate patients about signs and symptoms of ectopic pregnancy

Warnings

Risk of uterine perforation during insertion which may cause injury to other organs
Possibility of partial or complete expulsion leading to loss of contraceptive protection
Increased risk of pelvic inflammatory disease, particularly in presence of untreated STIs
Ectopic pregnancy risk if conception occurs with IUD in place; medical emergency if suspected
Severe infection may lead to infertility, sepsis, or require hysterectomy
Immediate post-insertion adverse events such as syncope or bradycardia in predisposed individuals
Not protective against HIV/AIDS or other sexually transmitted infections
Device embedment into myometrium complicating removal, may require surgical intervention
Prolonged heavy menstrual bleeding leading to anemia may require medical attention
Careful assessment required before insertion in postpartum or breastfeeding patients
Device failure risk if threads are not palpable or IUD position is unknown
Avoid insertion in patients with active genital infections or unexplained genital bleeding
Inform patients that Paragard does not prevent sexually transmitted infections
Removal must occur at or before 10 years from insertion to maintain contraceptive efficacy
Patients should seek immediate care for severe abdominal pain or abnormal bleeding after insertion

Contraindication

Known or suspected pregnancy
Abnormal uterine cavity (e.g., distorted by large fibroids or congenital anomalies)
Active pelvic inflammatory disease or current untreated pelvic infection
History of pelvic infection within 3 months postpartum or following abortion
Known or suspected uterine or cervical cancer
Unexplained abnormal vaginal bleeding
Untreated lower genital tract infection (cervicitis)
Wilson’s disease or known disorder of copper metabolism
Allergy to copper, polyethylene, or barium sulfate components of the device
Existing intrauterine device already in place at time of insertion
Postpartum uterine infection or recent endometritis
Known or suspected immunosuppression predisposing to severe infection
Severe uterine bleeding disorders or coagulopathies contraindicating insertion
Patients unwilling to use or unable to comply with follow-up visits and self-checks
Conditions increasing risk of uterine perforation or device expulsion

Drug Interactions

No significant drug interactions due to local mode of action and minimal systemic absorption
Concomitant use of antibiotics does not reduce contraceptive efficacy
Systemic medications do not interfere with copper ion release or local contraceptive effect
No noted interactions with hormonal contraceptives if used concurrently
No interaction with antifungal, antiviral, or anti-inflammatory medications
Drugs inducing metallic ion chelation theoretically may alter copper levels but no clinical relevance noted
No interaction with herbal supplements or dietary changes
No compromised efficacy with use of spermicides or barrier contraceptives
No effect of Paragard on metabolism of co-administered drugs
No interaction with antiretroviral agents used in HIV management
No impact on or from systemic anticoagulants or antiplatelet drugs unlike hormonal contraceptives
No evidence of altered plasma copper levels impacting other therapies
No interactions requiring dose adjustments identified
Safe with vaccines including HPV and influenza vaccines
Does not affect laboratory tests or diagnostic imaging beyond radiopaque presence

Preparations Of The Drug

Paragard consists of a flexible T-shaped polyethylene device with barium sulfate for X-ray visibility
Copper wire wrapped around the vertical stem and copper sleeves on horizontal arms constitute active contraceptive material
Two soft, flexible white nylon threads attached to the lower stem facilitate placement checks and removal
Non-hormonal copper-releasing IUD designed for intrauterine placement
Sterile, single-use device packaged individually for insertion by healthcare professionals
Inactive ingredients include polyethylene glycol and barium sulfate
Device dimensions engineered for intracavitary uterine fit and contraceptive efficacy
Manufactured by CooperSurgical, Inc., maintaining standard quality controls
Requires professional insertion under aseptic conditions in an outpatient setting
Supplied with detailed insertion instructions and patient educational materials
Storage recommended at controlled room temperature between 15° to 30°C (59° to 86°F)
Intended for up to 10 years of contraceptive use subject to periodic clinical assessment
May be replaced immediately upon removal if ongoing contraception desired
Cannot be modified or compounded; only manufacturer-prepared device suitable for use
Available exclusively as an intrauterine device without oral or injectable formulations